The global AI/ML and computational tools market in RNA research and therapeutics is anticipated to grow at a remarkable 26.8% CAGR from 2025 to 2034, driven by advancements in RNA biology, high-throughput sequencing, and the demand for efficient drug discovery solutions. Artificial Intelligence (AI) and Machine Learning (ML) are pivotal for optimizing RNA-targeted therapies, including mRNA vaccines and RNA interference (RNAi) treatments. Key applications span RNA structure prediction and therapeutic development, supported by robust bioinformatics tools and algorithms. Major players in this sector include Deep Genomics, Insilico Medicine, and NVIDIA. North America leads the market, benefiting from a strong biotech ecosystem and a supportive regulatory framework. Nevertheless, challenges remain such as dataset variability and delivery inefficiencies. By leveraging AI and ML, innovative therapeutic solutions are emerging, enhancing disease treatment strategies across various conditions. For insights and detailed analysis, explore our comprehensive market report.
Source link
Share
Read more